Ir para o conteúdo principal

AustraliaFinancial

Bloomberg
Financial

India's 'Biotech Queen' Doubles Down on Drug Access

Known as India's 'Queen of Biotech', Kiran Mazumdar-Shaw built Biocon from a rented garage almost 50 years ago. Today, her multibillion-dollar company is one of the world's biggest producers of insulin, and a leading force in biosimilars. As she looks at handing over her life's work to successors, Mazumdar-Shaw talks to Bloomberg's Haslinda Amin about her pioneering journey as a female entrepreneur in India, her mission to deliver life-saving therapies to patients and what she believes India must do to tackle an AI future.

Leia mais
Bloomberg
Financial

Mazumdar Shaw's Mission to Expand Access to Vital Drugs

Known as India's 'Queen of Biotech', Kiran Mazumdar-Shaw built Biocon from a rented garage almost 50 years ago. Today, her multibillion-dollar company is one of the world's biggest producers of insulin, and a leading force in biosimilars. As she looks at handing over her life's work to successors, Mazumdar-Shaw talks to Bloomberg's Haslinda Amin about her pioneering journey as a female entrepreneur in India, her mission to deliver life-saving therapies to patients and what she believes India must do to tackle an AI future.

Leia mais
Bloomberg
Financial

Maisonette Tackles "Untapped" Retail Market

The curated online marketplace Maisonette is expanding it to what it describes as an untapped market by launching a new platform targeted to tweens and teens. President AJ Nicholas saying the company is looking to tap into the demographic of kids that "start to exert some independence and autonomy and really have a say over their style." As Maisonette has been around for 9 years, Nicholas says its important that the company grows organically as its customers' families grow up as well, allowing them to expand further into the more than $225 Billion industry.

Leia mais
Bloomberg
Financial

Broadcom Seeking $60B in AI Debt Deal

Broadcom Inc. is in talks with a group of lenders to raise more than $60 billion in debt for an AI chip financing deal that will benefit Anthropic PBC and other companies, according to people with knowledge of the matter. The financing, which is still being ironed out, may also include a roughly $30 billion junior debt tranche, said some of the people, who asked not to be identified because the information is private. Bloomberg News Deals Reporter Ryan Gould breaks down the significance of a potential deal, and who the players may be.

Leia mais
Bloomberg
Financial

Open Machine CEO on Anthropic, OpenAI IPO Potential

Allie Miller, CEO of Open Machine, shared insights on how top technology companies are managing their AI investments to balance cost and return. She explained that frontier companies typically divide their AI efforts into two groups: one focused on raising the baseline capabilities across departments like finance, legal, marketing, and sales with modest subscription-level spending, and a second, smaller 'frontier' team that operates with significantly higher budgets and greater experimentation freedom. She speaks with Romaine Bostick on "The Close."

Leia mais
Bloomberg
Financial

J&J Snack Foods CEO on Snack Nostalgia, Turnaround Plans

Dan Fachner, CEO of J&J Snack Foods, discussed the company's strategic focus on the food service segment, which accounts for 60% of its business. He emphasized the strong recovery and growth potential in experiential venues such as theaters, theme parks, and ballparks, where iconic brands like ICEE, Dippin' Dots, and Super Pretzel are popular. He speaks with Romaine Bostick on "The Close."

Leia mais
Bloomberg
Financial

Agility Robotics CEO on Plans To Go Public, China Rivals

Peggy Johnson, CEO of Agility Robotics, discussed the company's upcoming public debut, positioning it as the only pure-play US public company focused on humanoid robots with proven commercial applications. Agility Robotics is valued at a $2.5 billion pre-money valuation and expects to go public in the fall. She speaks with Romaine Bostick & Sally Bakewell on "The Close."

Leia mais